Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Correlation between Motor Cortex Excitability Changes and Cognitive Impairment in Vascular Depression: Pathophysiological Insights from a Longitudinal TMS Study.

Pennisi M, Lanza G, Cantone M, Ricceri R, Spampinato C, Pennisi G, Di Lazzaro V, Bella R.

Neural Plast. 2016;2016:8154969. doi: 10.1155/2016/8154969. Epub 2016 Jul 20.

2.

Neurochemical Changes Associated with Stress-Induced Sleep Disturbance in Rats: In Vivo and In Vitro Measurements.

Lee DW, Chung S, Yoo HJ, Kim SJ, Woo CW, Kim ST, Lee DH, Kim KW, Kim JK, Lee JS, Choi CG, Shim WH, Choi Y, Woo DC.

PLoS One. 2016 Apr 14;11(4):e0153346. doi: 10.1371/journal.pone.0153346. eCollection 2016.

3.

Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer.

Prabhavalkar KS, Poovanpallil NB, Bhatt LK.

Front Pharmacol. 2015 Oct 23;6:242. doi: 10.3389/fphar.2015.00242. eCollection 2015. Review.

4.
5.

Advances in the Management of Treatment-Resistant Depression.

Holtzheimer PE.

Focus (Am Psychiatr Publ). 2010 Fall;8(4):488-500.

6.

Emerging Novel Treatments for Severe Mood Disorders Involving Cellular Plasticity Cascades.

Machado-Vieira R, Zarate CA Jr, Manji HK.

Curr Psychos Ther Rep. 2006 Dec;4(4):181-190.

7.

Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action.

Du J, Machado-Vieira R, Maeng S, Martinowich K, Manji HK, Zarate CA Jr.

Drug Discov Today Ther Strateg. 2006 Winter;3(4):519-526.

8.

NCAM140 and pCREB Expression after Tianeptine Treatment of SH-SY5Y Cells.

Lee MG, Oh D, Choi MR, Chai YG, Kim SH, Oh DH, Choi J.

Psychiatry Investig. 2014 Jul;11(3):313-8. doi: 10.4306/pi.2014.11.3.313. Epub 2014 Jul 21.

9.
10.

Assessing the effects of electroconvulsive therapy on cortical excitability by means of transcranial magnetic stimulation and electroencephalography.

Casarotto S, Canali P, Rosanova M, Pigorini A, Fecchio M, Mariotti M, Lucca A, Colombo C, Benedetti F, Massimini M.

Brain Topogr. 2013 Apr;26(2):326-37. doi: 10.1007/s10548-012-0256-8. Epub 2012 Oct 9.

11.

The same antidepressant elicits contrasting patterns of synaptic changes in the amygdala vs hippocampus.

Pillai AG, Anilkumar S, Chattarji S.

Neuropsychopharmacology. 2012 Nov;37(12):2702-11. doi: 10.1038/npp.2012.135. Epub 2012 Jul 25.

12.

Mifepristone prevents stress-induced apoptosis in newborn neurons and increases AMPA receptor expression in the dentate gyrus of C57/BL6 mice.

Llorens-Martín M, Trejo JL.

PLoS One. 2011;6(11):e28376. doi: 10.1371/journal.pone.0028376. Epub 2011 Nov 30.

13.

Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking.

Du J, Quiroz JA, Gray NA, Szabo ST, Zarate CA Jr, Manji HK.

Dialogues Clin Neurosci. 2004 Jun;6(2):143-55.

14.

Novel glutamatergic agents for major depressive disorder and bipolar disorder.

Machado-Vieira R, Ibrahim L, Henter ID, Zarate CA Jr.

Pharmacol Biochem Behav. 2012 Feb;100(4):678-87. doi: 10.1016/j.pbb.2011.09.010. Epub 2011 Sep 25. Review.

15.

Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder.

Ramadan E, Basselin M, Rao JS, Chang L, Chen M, Ma K, Rapoport SI.

Int J Neuropsychopharmacol. 2012 Aug;15(7):931-43. doi: 10.1017/S1461145711001003. Epub 2011 Jun 28.

16.

Activity-regulated genes as mediators of neural circuit plasticity.

Leslie JH, Nedivi E.

Prog Neurobiol. 2011 Aug;94(3):223-37. doi: 10.1016/j.pneurobio.2011.05.002. Epub 2011 May 12. Review.

17.

Glutamatergic modulators: the future of treating mood disorders?

Zarate C Jr, Machado-Vieira R, Henter I, Ibrahim L, Diazgranados N, Salvadore G.

Harv Rev Psychiatry. 2010 Sep-Oct;18(5):293-303. doi: 10.3109/10673229.2010.511059. Review.

18.

Lithium acts as a potentiator of AMPAR currents in hippocampal CA1 cells by selectively increasing channel open probability.

Gebhardt C, Cull-Candy SG.

J Physiol. 2010 Oct 15;588(Pt 20):3933-41. doi: 10.1113/jphysiol.2010.195115. Epub 2010 Aug 31.

19.

New therapeutic targets for mood disorders.

Machado-Vieira R, Salvadore G, DiazGranados N, Ibrahim L, Latov D, Wheeler-Castillo C, Baumann J, Henter ID, Zarate CA Jr.

ScientificWorldJournal. 2010 Apr 13;10:713-26. doi: 10.1100/tsw.2010.65. Review.

20.

The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation.

McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, Fuchs E.

Mol Psychiatry. 2010 Mar;15(3):237-49. doi: 10.1038/mp.2009.80. Epub 2009 Aug 25. Review.

Items per page

Supplemental Content

Write to the Help Desk